Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Genedx Holdings's Business Segments
Genedx Holdings's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q1 FY2026
Reportable Segments
2
Largest Segment
GeneDx
Total Revenue
$ 102
Regions Reported
-
Revenue Share by Reportable Segment - Q1 FY2026
- GeneDx99.3%
- Other Operating0.7%
Revenue by Reportable Segment - Q1 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| GeneDx | $ 101 | 99.3% |
| Other Operating | $ 1 | 0.7% |
Revenue by Product & Service Category - Q1 FY2026
- Diagnostic Test99.1%
- Diagnostic Test, Third Party Insurance83.1%
- Diagnostic Test, Institutional Customers15.2%
- Product and Service, Other0.9%
- Diagnostic Test, Self Pay0.3%
Revenue by Product & Service Category - Q1 FY2026
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Diagnostic Test | $ 101 | 99.1% |
| Diagnostic Test, Third Party Insurance | $ 85 | 83.1% |
| Diagnostic Test, Institutional Customers | $ 16 | 15.2% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
2 more categories available
Sign in to unlock the full Genedx Holdings dataset.
Description of Genedx Holdings
Genedx Holdings Corp is a leading provider of genetic testing and diagnostics headquartered in Gaithersburg, Maryland, United States. The company offers comprehensive genetic testing solutions that help healthcare professionals in accurate diagnosis, personalized treatment plans, and counseling for patients and their families. Genedx was founded in 2000 and has established a strong reputation in the field of genetic testing over the years.
The organization plays a crucial role in the healthcare industry by contributing to the understanding of genetic disorders, supporting the identification of disease-causing genetic variants, and improving patient outcomes. Genedx specializes in providing testing for rare and ultra-rare genetic disorders, as well as complex genetic conditions and diseases with a genetic component.
The company's comprehensive test menu includes a wide range of offerings such as single-gene testing, gene panels, exome sequencing, whole genome sequencing, and array comparative genomic hybridization (aCGH). These tests cover various areas including cardiology, neurology, oncology, endocrinology, immunology, and many more. Genedx collaborates with physicians, genetic counselors, researchers, and pharmaceutical companies to provide the most advanced and effective genetic testing solutions.
Genedx is known for its state-of-the-art laboratory facilities, equipped with cutting-edge technology and operated by highly skilled laboratory professionals. The company adheres to the highest quality and regulatory standards, ensuring accurate and reliable test results. Additionally, Genedx has a robust bioinformatics infrastructure that includes sophisticated algorithms and databases to aid in the interpretation of genetic data.
In addition to its diagnostic services, Genedx is actively involved in research and development aimed at advancing the field of genetics. The company's commitment to innovation is reflected in its participation in various scientific conferences, collaborations with research institutions, and publishing scientific literature.
Genedx is focused on providing exceptional customer service and support. The company offers a dedicated team of genetic counselors to guide healthcare professionals and patients through the testing process, provide result interpretations, and offer genetic counseling services. Genedx also maintains a web portal where healthcare professionals can access test requisitions, track the progress of tests, and view test results securely.
Acquired by Apax Partners in 2020, Genedx has continued to expand its capabilities and reach within the genetic testing industry. Through strategic partnerships and collaborations, the company aims to further advance its research efforts and broaden its portfolio of genetic testing services.
In summary, Genedx Holdings Corp is a prominent player in the field of genetic testing and diagnostics, offering an extensive range of tests for various genetic disorders and conditions. The company's commitment to excellence, technological advancements, and strong focus on customer support has helped establish its position as a trusted provider of genetic testing solutions.
The organization plays a crucial role in the healthcare industry by contributing to the understanding of genetic disorders, supporting the identification of disease-causing genetic variants, and improving patient outcomes. Genedx specializes in providing testing for rare and ultra-rare genetic disorders, as well as complex genetic conditions and diseases with a genetic component.
The company's comprehensive test menu includes a wide range of offerings such as single-gene testing, gene panels, exome sequencing, whole genome sequencing, and array comparative genomic hybridization (aCGH). These tests cover various areas including cardiology, neurology, oncology, endocrinology, immunology, and many more. Genedx collaborates with physicians, genetic counselors, researchers, and pharmaceutical companies to provide the most advanced and effective genetic testing solutions.
Genedx is known for its state-of-the-art laboratory facilities, equipped with cutting-edge technology and operated by highly skilled laboratory professionals. The company adheres to the highest quality and regulatory standards, ensuring accurate and reliable test results. Additionally, Genedx has a robust bioinformatics infrastructure that includes sophisticated algorithms and databases to aid in the interpretation of genetic data.
In addition to its diagnostic services, Genedx is actively involved in research and development aimed at advancing the field of genetics. The company's commitment to innovation is reflected in its participation in various scientific conferences, collaborations with research institutions, and publishing scientific literature.
Genedx is focused on providing exceptional customer service and support. The company offers a dedicated team of genetic counselors to guide healthcare professionals and patients through the testing process, provide result interpretations, and offer genetic counseling services. Genedx also maintains a web portal where healthcare professionals can access test requisitions, track the progress of tests, and view test results securely.
Acquired by Apax Partners in 2020, Genedx has continued to expand its capabilities and reach within the genetic testing industry. Through strategic partnerships and collaborations, the company aims to further advance its research efforts and broaden its portfolio of genetic testing services.
In summary, Genedx Holdings Corp is a prominent player in the field of genetic testing and diagnostics, offering an extensive range of tests for various genetic disorders and conditions. The company's commitment to excellence, technological advancements, and strong focus on customer support has helped establish its position as a trusted provider of genetic testing solutions.
GeneDx Holdings Corp. was primarily focused on genetic testing and related services. GeneDx specializes in providing a wide range of genetic testing solutions that cater to various medical and healthcare needs. Below is a detailed description of the segments, products, and services offered by GeneDx:
Segments
1. Clinical Genetic Testing:
- Carrier Screening: Testing to determine if an individual carries a gene for a specific genetic disorder, which can be critical for family planning.
- Diagnostic Testing: Testing conducted to confirm or rule out a specific genetic condition in patients showing symptoms.
- Exome Sequencing: Comprehensive examination of the protein-coding regions of genes to identify mutations that could lead to genetic disorders.
2. Prenatal Testing:
- Non-Invasive Prenatal Testing (NIPT): A blood test that assesses the risk of certain genetic conditions in a fetus, offering early insights into potential disorders.
3. Specialty Genetic Testing:
- Aimed at specific areas such as oncology, cardiovascular conditions, and rare diseases, these tests provide targeted insights that are crucial for treatment decisions.
4. Pharmacogenomics:
- A segment that assesses how genetic variations impact an individuals response to specific medications, allowing healthcare providers to tailor treatments based on genetic profiles.
Products
1. Genetic Test Panels:
- Comprehensive panels that assess multiple genes associated with a particular condition or set of conditions.
- Designed for specific disorders, including but not limited to cardiovascular diseases, neurological disorders, and cancer predisposition syndromes.
2. Whole Exome Sequencing (WES):
- This product focuses on sequencing all coding regions of genes, giving clinicians a broad overview of potential genetic anomalies.
3. Whole Genome Sequencing (WGS):
- An advanced product that analyzes the entire genome, providing the most exhaustive genetic information available.
4. Variant Interpretation Tools:
- Software and analytic tools that help doctors understand the clinical significance of genetic variants identified in testing.
Services
1. Genetic Counseling:
- GeneDx offers access to genetic counselors who provide expert guidance to patients and families. This service helps interpret test results and understand the implications for health, wellness, and family planning.
2. Clinical Support Services:
- Dedicated support for healthcare providers in interpreting results, making informed decisions, and integrating genetic testing into patient care.
3. Research and Development Services:
- Collaborations with research institutions and pharmaceutical companies to advance genetic research, improve testing methodologies, and contribute to the understanding of genetic diseases.
4. Educational Resources:
- Providing educational tools and materials for healthcare providers and patients to better understand genetic testing and its importance.
Conclusion
GeneDx Holdings Corp. is deeply entrenched in the genetic testing industry, offering a robust portfolio of tests designed to meet a variety of clinical needs—from carrier and prenatal screening to diagnostic services and pharmacogenomics. Their services are tailored toward enhancing clinical outcomes, supporting healthcare professionals, and improving patient understanding of genetic health. This strategic focus positions GeneDx at the forefront of precision medicine, playing a crucial role in the evolving landscape of genomic healthcare.
Segments
1. Clinical Genetic Testing:
- Carrier Screening: Testing to determine if an individual carries a gene for a specific genetic disorder, which can be critical for family planning.
- Diagnostic Testing: Testing conducted to confirm or rule out a specific genetic condition in patients showing symptoms.
- Exome Sequencing: Comprehensive examination of the protein-coding regions of genes to identify mutations that could lead to genetic disorders.
2. Prenatal Testing:
- Non-Invasive Prenatal Testing (NIPT): A blood test that assesses the risk of certain genetic conditions in a fetus, offering early insights into potential disorders.
3. Specialty Genetic Testing:
- Aimed at specific areas such as oncology, cardiovascular conditions, and rare diseases, these tests provide targeted insights that are crucial for treatment decisions.
4. Pharmacogenomics:
- A segment that assesses how genetic variations impact an individuals response to specific medications, allowing healthcare providers to tailor treatments based on genetic profiles.
Products
1. Genetic Test Panels:
- Comprehensive panels that assess multiple genes associated with a particular condition or set of conditions.
- Designed for specific disorders, including but not limited to cardiovascular diseases, neurological disorders, and cancer predisposition syndromes.
2. Whole Exome Sequencing (WES):
- This product focuses on sequencing all coding regions of genes, giving clinicians a broad overview of potential genetic anomalies.
3. Whole Genome Sequencing (WGS):
- An advanced product that analyzes the entire genome, providing the most exhaustive genetic information available.
4. Variant Interpretation Tools:
- Software and analytic tools that help doctors understand the clinical significance of genetic variants identified in testing.
Services
1. Genetic Counseling:
- GeneDx offers access to genetic counselors who provide expert guidance to patients and families. This service helps interpret test results and understand the implications for health, wellness, and family planning.
2. Clinical Support Services:
- Dedicated support for healthcare providers in interpreting results, making informed decisions, and integrating genetic testing into patient care.
3. Research and Development Services:
- Collaborations with research institutions and pharmaceutical companies to advance genetic research, improve testing methodologies, and contribute to the understanding of genetic diseases.
4. Educational Resources:
- Providing educational tools and materials for healthcare providers and patients to better understand genetic testing and its importance.
Conclusion
GeneDx Holdings Corp. is deeply entrenched in the genetic testing industry, offering a robust portfolio of tests designed to meet a variety of clinical needs—from carrier and prenatal screening to diagnostic services and pharmacogenomics. Their services are tailored toward enhancing clinical outcomes, supporting healthcare professionals, and improving patient understanding of genetic health. This strategic focus positions GeneDx at the forefront of precision medicine, playing a crucial role in the evolving landscape of genomic healthcare.